Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-09 | Aquestive Therapeutics, Inc. | Schobel Alexander...
(Chief Innovation/Tech Officer) |
F | Common Stock | D | 9645 | $4.88 - $4.88 | $47,067 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Wargacki Stephen
(Chief Science Officer) |
F | Common Stock | D | 19505 | $4.88 - $4.88 | $95,184 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Barber Daniel
(President and CEO) |
F | Common Stock | D | 56824 | $4.88 - $4.88 | $277,301 |
| 2024-03-09 | Aquestive Therapeutics, Inc. | Jung Cassie
(SVP, Operations) |
F | Common Stock | D | 14120 | $4.88 - $4.88 | $68,905 |
| 2024-08-09 | Aquestive Therapeutics, Inc. | Kraus Carl N
(Chief Medical Officer) |
F | Common Stock | D | 10819 | $3.43 - $3.43 | $37,109 |
| 2024-06-07 | Aquestive Therapeutics, Inc. | Korczynski Sherry
(SVP Sales and Marketing) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |